|
Market Closed -
Nasdaq Stockholm
21:00:00 12/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.3195 SEK | 0.00% |
|
-6.03% | -61.46% |
| 11-12 | Alzinova narrows loss | FW |
| 11-12 | Alzinova AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 10.12M | - | - | - | - | - |
| 67.53B | |||||
| 60.74B | |||||
| 55.66B | |||||
| 47.97B | |||||
| 45.24B |
- Stock Market
- Stocks
- ALZ Stock
- Charts Alzinova AB
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
